Extraosseous Ewing's sarcoma of the pancreas

Prithviraj Bose, Paari Murugan, Elizabeth Gillies, Jennifer L. Holter

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Abstract

The Ewing's family of tumors (EFT) comprises a molecularly defined group of ''small round blue cell tumors'', consisting of Ewing's sarcoma of bone (ESB), extraosseous Ewing's sarcoma (EES), peripheral primitive neuroectodermal tumor (pPNET), and Askin's tumor. Characteristic translocations that disrupt the EWSR1 gene located at 22q12 create novel fusion genes that are central to the pathogenesis. The EFT also shares certain clinical characteristics, such as a peak incidence during the teenage years, a tendency to spread rapidly, and responsiveness to the same chemotherapeutic regimens and radiation therapy. Nearly all patients have occult disseminated disease at diagnosis; hence, chemotherapy is routinely used. Improvements in multimodality treatment have had a dramatic impact on outcomes. EES/pPNET has been reported in a variety of sites, including the pancreas, though this is extremely rare. We describe a case of pancreatic EES/ pPNET in a 35-year-old woman and provide a brief review of the relevant literature.

Original languageEnglish (US)
Pages (from-to)399-406
Number of pages8
JournalInternational Journal of Clinical Oncology
Volume17
Issue number4
DOIs
StatePublished - Aug 2012

Keywords

  • Ewing's sarcoma
  • Extraosseous Ewing's sarcoma
  • PNET
  • Pancreas
  • Primitive neuroectodermal tumor

Fingerprint Dive into the research topics of 'Extraosseous Ewing's sarcoma of the pancreas'. Together they form a unique fingerprint.

Cite this